Kingston, Ontario, 15 December 2020 – Octane Medical Group has expanded its state-of-the-art facility in Kingston, Ontario Canada.

The 40,000-square-foot building, which Octane purchased in 2011, houses the company’s head office and features regulated biolabs for biomaterial and biologics discovery programs including cell therapy research and development, a fully equipped cleanroom and manufacturing floor for production of medical devices, biomaterials, instrumentation and disposable components for clinical systems.

“With our new facility, we are well-positioned for further growth in our multiple business units and for continued advances in our regenerative medicine innovations”, says Octane CEO Tim Smith. “It’s another big step forward in our journey.”

For press inquiries please contact Renee Thibodeau.
renee.thibodeau@octaneco.com
613-634-6345 x200

Cocoon™ is a patient-scale cell therapy system that forms the core of a series of versatile cell and tissue therapy production systems. Unlike other bioreactor systems, this platform integrates multiple steps, including upstream and downstream processing. From cell source isolation and cell expansion, through to cell collection, cell washing and final product formation – all in a closed, single-use disposable cassette

Coupled with advanced bioreactors, biosensor feedback and innovative cell scaffolds, this cell culture and tissue engineering platform opens up an array of clinical applications. Cocoon is an integrated turnkey production solution that can be configured as a compact but powerful system with a small footprint, or as a multi-patient system for ultra-efficient, enterprise-level deployment. Please read more about our game-changing innovations in regenerative medicine .

‍